SEC Comment Letter for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) (CIK 0000818686) (TEVA) — Jul 21, 2008

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) (CIK 0000818686)
Date: July 21, 2008 · CIK: 0000818686 · Accession: 0000000000-08-036051

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 000-16174

Date

July 21, 2008

Author

Not clearly detected

Form

UPLOAD

Company

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) (CIK 0000818686)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 July 21, 2008 Mr. Dan S. Suesskind Chief Financial Officer Teva Pharmaceutical Industries Limited 5 Basel Street PO Box 3190 Petach Tikva 49131, Israel Re: Teva Pharmaceutical Industries Limited Form 20-F for the Year Ended December 31, 2007 File No. 000-16174

Dear Mr. Suesskind: We have completed our review of your Fo rm 20-F and have no further comments at this time. S i n c e r e l y ,

Carlton Tartar Accounting Branch Chief

Show Raw Text

Via Facsimile and U.S. Mail Mail Stop 6010                                                                                                  July 21, 2008   Mr. Dan S. Suesskind Chief Financial Officer Teva Pharmaceutical Industries Limited 5 Basel Street PO Box 3190 Petach Tikva 49131, Israel
Re: Teva Pharmaceutical Industries Limited
 Form 20-F for the Year Ended December 31, 2007  File No. 000-16174

Dear Mr. Suesskind:
  We have completed our review of your Fo rm 20-F and have no further comments at
this time.
        S i n c e r e l y ,

Carlton Tartar Accounting Branch Chief

SecProbe.io